{
  "docId": "019de517-ef27-7380-abf1-7804147a21c1",
  "docSlug": "35bb8af5e32b82874d7685e3939f2cc9",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 39 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 39,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "overcrowded",
  "nDataPoints": 15,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de517-ef27-7380-abf1-7804147a21c1/7",
  "deckHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1",
  "deckJsonHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1.json",
  "deckAnchorHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.21,
        "w": 0.26,
        "x": 0.07,
        "y": 0.249
      },
      "kind": "chart",
      "text": "B+L CC Revenue Growth¹: FY22 +5%, FY23 +12%",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10e83562-c707-4728-8db2-54fe871d1d9a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.32,
        "w": 0.26,
        "x": 0.07,
        "y": 0.55
      },
      "kind": "chart",
      "text": "B+L Reported Revenue: FY22 $3,768M, FY23 $4,146M",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ea3d9744-0b3f-4589-80c4-5cf10b05d27e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.28,
        "x": 0.68,
        "y": 0.249
      },
      "kind": "list",
      "text": "FY23 Key Franchise Reported Revenue Growth: INFUSE ULTRA 46%, VYZULTA 35%, LUMIFY 27%, envistatoric LUX IC8 24%, Artelac 20%, Bio Multipurpose true Solution 9%, PreserVision Ocuvite 6%",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "175bdfb3-193c-472e-a1e3-53555e2ac1d4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.27,
        "x": 0.38,
        "y": 0.195
      },
      "kind": "list",
      "text": "Growth Across All Segments",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c36bcfa-8422-495d-96c5-2ec8906957c5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.28,
        "x": 0.68,
        "y": 0.195
      },
      "kind": "list",
      "text": "Growth in All Key Franchises",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "53370e85-806d-4b27-bab1-6d11e29140a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.3,
        "x": 0.35,
        "y": 0.249
      },
      "kind": "list",
      "text": "FY23 Segment CC Revenue Growth¹: Vision Care +10%, Surgical +7%, Pharmaceuticals +24%",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84f458d2-5fd9-4e7d-9805-21664e14dbeb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.29,
        "x": 0.07,
        "y": 0.195
      },
      "kind": "list",
      "text": "Delivered +12% Growth CC FY23",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f722a232-0e29-47ff-829e-ca0ca9c24ef4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.76,
        "x": 0.15,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1. Constant currency. This is a non-GAAP measure or ratio. See Slide 1 and Appendix for further information on non-GAAP measures or ratios.\n2. Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the reported results of the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar products. The net impact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc452679-5ff5-41d1-b918-b44311597afe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.709,
        "x": 0.046,
        "y": 0.049
      },
      "kind": "title",
      "text": "Strong Performance Across All Segments",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "956601bb-3944-4dcb-b762-ece2947a6cdc",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 7,
      "from": 5,
      "beatId": "edabbcb8-7646-4682-98c8-d3486f51f9e7",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Interest",
      "beatSlug": "aida-interest",
      "evidence": "The roadmap and performance overview generate interest in the company's progress",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}